IP Library Patent Application 13494237
Patent Application
App. No. 13/494,237

PRODUCTS FOR ANTI-INFLAMMATION SUPPORT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/494,237
Abstract

This disclosure provides products, including pharmaceutical compositions and dietary supplements, which are useful for anti-inflammatory support.

Claims (26)

1 . A product comprising:

a compound of Formula I

wherein R represents hydrogen or C 1 -C 5 alkyl; R′ represents hydrogen or C 1 -C 7 alkyl; and X represents halogen or C 1 -C 7 alkyl, or a pharmaceutically acceptable salt thereof; and

a vitamin.

2 . The product of claim 1 , wherein R represents hydrogen or C 1 -C 3 alkyl.

3 . The product of claim 1 , wherein R′ represents hydrogen or C 1 -C 4 alkyl.

4 . The product of claim 1 , wherein X represents halogen or C 1 -C 3 alkyl.

5 . The product of claim 1 , wherein the compound is anatabine.

6 . The product of claim 5 , wherein the compound is S-(−)-anatabine.

7 . The product of claim 5 , wherein the compound is R-(+)-anatabine.

8 . The product of claim 1 , wherein the vitamin is Vitamin A.

9 . The product of claim 1 , wherein the vitamin is Vitamin D3.

10 . The product of 8 , further comprising Vitamin D3.

11 . The product of claim 5 , wherein the anatabine is synthetic anatabine.

12 . The product of claim 5 , wherein the anatabine is provided in the form of an extract from a plant.

13 . The product of claim 5 , which comprises anatabine in an amount of about 1 mg.

14 . The product of claim 1 , which comprises Vitamin A in an amount of about 417 IU.

15 . The product of claim 1 , comprising Vitamin D3 in an amount of about 33 IU.

16 . The product of claim 1 , further comprising one or more additional ingredients selected from the group consisting of mannitol, natural and artificial mint flavors, sucralose, silicon dioxide, stearic acid, hydroxypropyl methylcellulose, magnesium stearate, titanium dioxide, natural glaze, methyl parabens, propylparabens, triethyl citrate, citric acid, BHT, mono and diglycerides, and polysorbate 80.

17 . The product of claim 1 , which is a dietary supplement.

18 . The product of claim 1 , which is a pharmaceutical composition.

19 . A method of providing anti-inflammation support, comprising administering to an individual in need thereof a product comprising:

a compound of Formula I

wherein R represents hydrogen or C 1 -C 5 alkyl; R′ represents hydrogen or C 1 -C 7 alkyl; and X represents halogen or C 1 -C 7 alkyl, or a pharmaceutically acceptable salt thereof; and

a vitamin.

20 . The method of claim 19 , wherein the individual is human.

Assignments (2)
CHANGE OF NAME Recorded Jul 14, 2014
From: ROCK CREEK PHARMACEUTICALS, INC.
To: RCP DEVELOPMENT, INC.
Reel/Frame 033309/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 3, 2012
From: WILLIAMS, JONNIE R.
To: ROCK CREEK PHARMACEUTICALS, INC.
Reel/Frame 028484/0803 →